Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets


September 1, 2011
372 Pages - SKU: WA6556362
License type:
Table of Contents Related Reports
Countries covered: Global



The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.

Contract manufacturing of OTC and nutritional products worldwide reached at $114.8 billion in 2010, it will further grow to $127.9 billion in 2011 and is projected to reach at $214.5 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.9%.

Contract manufacturing of bulk and dosage form drugs worldwide reached at $48.6 billion in 2010, it will further grow to $53.4 billion in 2011 and is projected to reach at $86.3 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.1%.



More Regulation & Policy reports by BCC Research

Global Markets for Orphan Drugs – Focus on Non-Biologics by BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug ...
Global Markets for Orphan Drugs – Focus on Biologics by BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug ...
Global Markets for Orphan Drugs by BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, ...
Botanical and Plant-Derived Drugs: Global Markets by BCC Research
This report provides: An overview of the botanical drug industry, with the overall plant-derived drug industry as a backdrop and the global market for these ...
See all reports like this >>

More Global Regulation & Policy reports

The World Market for Orphan Drugs by Kalorama Information
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The ...
Global Markets for Orphan Drugs – Focus on Non-Biologics by BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug ...
Global Markets for Orphan Drugs – Focus on Biologics by BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug ...
Global Markets for Orphan Drugs by BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Regulation & Policy Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!